Integra Lifesciences Holdings Corp financial data

Symbol
IART on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
1100 Campus Road, Princeton, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
INTEGRA LIFESCIENCES CORP (to 3/31/1999)
Latest financial report
10-K - Q4 2024 - Feb 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 191 % -39.4%
Quick Ratio 68.6 % -37.9%
Debt-to-equity 162 % +24.3%
Return On Equity -0.45 % -111%
Return On Assets -0.17 % -109%
Operating Margin 1.76 % -75.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 77.2M shares -2.01%
Entity Public Float 2.19B USD -32.8%
Common Stock, Value, Issued 916K USD +0.77%
Weighted Average Number of Shares Outstanding, Basic 77M shares -3.84%
Weighted Average Number of Shares Outstanding, Diluted 77M shares -4.14%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.61B USD +4.47%
Costs and Expenses 1.58B USD +10.6%
Operating Income (Loss) 28.4M USD -74.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -18.2M USD -122%
Income Tax Expense (Benefit) -11.3M USD -185%
Net Income (Loss) Attributable to Parent -6.94M USD -110%
Earnings Per Share, Basic -0.09 USD/shares -111%
Earnings Per Share, Diluted -0.09 USD/shares -111%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 246M USD -10.9%
Accounts Receivable, after Allowance for Credit Loss, Current 272M USD +5.03%
Inventory, Net 429M USD +10.1%
Other Assets, Current 29.7M USD -9.16%
Assets, Current 1.08B USD +2.24%
Deferred Income Tax Assets, Net 34.9M USD -24.2%
Property, Plant and Equipment, Net 406M USD +19.3%
Operating Lease, Right-of-Use Asset 144M USD -7.77%
Intangible Assets, Net (Excluding Goodwill) 1.21B USD +13.1%
Goodwill 1.1B USD +3.93%
Other Assets, Noncurrent 66.5M USD +14.3%
Assets 4.04B USD +6.75%
Employee-related Liabilities, Current 85.6M USD +13.5%
Accrued Liabilities, Current 122M USD +20.9%
Contract with Customer, Liability, Current 10.5M USD +22.8%
Liabilities, Current 922M USD +200%
Contract with Customer, Liability, Noncurrent 9.2M USD +19.5%
Deferred Income Tax Liabilities, Net 60.8M USD +72.2%
Operating Lease, Liability, Noncurrent 167M USD +0.05%
Other Liabilities, Noncurrent 146M USD -26.9%
Liabilities 2.49B USD +13.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -27.6M USD -82.5%
Retained Earnings (Accumulated Deficit) 940M USD -0.73%
Stockholders' Equity Attributable to Parent 1.55B USD -2.68%
Liabilities and Equity 4.04B USD +6.75%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 15.8M USD -39.8%
Net Cash Provided by (Used in) Financing Activities 359M USD
Net Cash Provided by (Used in) Investing Activities -54M USD -294%
Common Stock, Shares Authorized 240M shares 0%
Common Stock, Shares, Issued 91.6M shares +0.76%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 316M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 246M USD -10.9%
Deferred Tax Assets, Valuation Allowance 15.5M USD +24.2%
Deferred Tax Assets, Gross 240M USD +0.23%
Operating Lease, Liability 181M USD -0.36%
Payments to Acquire Property, Plant, and Equipment 15.5M USD +12.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -19.4M USD -146%
Lessee, Operating Lease, Liability, to be Paid 268M USD -1.62%
Property, Plant and Equipment, Gross 803M USD +13.4%
Operating Lease, Liability, Current 14.5M USD -4.87%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.1M USD -9.04%
Lessee, Operating Lease, Liability, to be Paid, Year One 23.3M USD +1.85%
Deferred Income Tax Expense (Benefit) -2.86M USD -246%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 86.8M USD -4.14%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.7M USD +1.23%
Deferred Tax Assets, Operating Loss Carryforwards 27.4M USD -4.96%
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 826K USD +1.72%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.9M USD -1.99%
Operating Lease, Payments 5.73M USD +32.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 21.3M USD +72%
Deferred Tax Assets, Net of Valuation Allowance 225M USD -1.09%
Interest Expense 52.9M USD +5.72%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares